INTRODUCTION
The human leukocyte antigen (HLA) class Ⅱ genes com prise a highly polymorphic region in the short arm of chromosome 6 and are responsible for the creation of molecules involved in exogenous antigen presentation to T cells [1, 2] . A subset of class Ⅱ genes, encoding the DQ2 and DQ8 serotypes, have been frequently implicated in autoimmune disease pathogenesis. Prevalent in 30%40% of healthy individuals, DQ2 and DQ8 are associated with diseases such as insulindependent diabetes mellitus and Hashimoto's Thyroiditis [3, 4] . These haplotypes may be best characterized through the gluten dependent rela tionship with celiac disease, an autoimmune mediated enteropathy affecting approximately 1% of Europeans and North Americans [57] . Consequently, many studies have attempted to estimate or infer the proportion of celiac disease risk due to particular DQ2/8 isoforms. For this reason, a genetic risk gradient has been recently characterized for DQ2/8 allele variants [8] . The risk as sociated with celiac disease compared to those healthy depends, incrementally, on the number/type of HLA al leles possessed by an individual. Those with one or both of the DQ2/8 alleles have a risk ranging from 1:71:35, while those lacking all potential immunogenic loci have a near zero chance of contracting celiac disease [8, 9] . Beyond celiac disease risk, disease severity and antitTg antibody levels are thought to be further tied to this disease/gene dose relationship [10] . There are several reasons why it may be prudent to study DQ2/8 alleles in liver/gastrointestinal (GI) disease outside of celiac disease. First, evidence suggests that celiac disease may modify the risk of developing irrita ble bowel syndrome (IBS), inflammatory bowel disease (IBD), eosinophilic esophagitis, or certain liver diseas es [1114] . Recent research has also shown the presence of HLA DQ2/8 alleles by themselves, outside of celiac dis ease, to be associated with GI disease [1517] . This suggests that DQ2/8 haplotypes may act as a common factor in liver/GI disease pathogenesis; possibly through a simi lar mechanism to that of celiac disease. Furthermore, as DQ2/8 haplotypes contain myriad genes involved in in flammatory processes, such as tumor necrosis factor-α, causal mechanisms between these genes and GI disease may exist [18] . Comparisons of DQ2/8 prevalence in non celiac GI diseases, however have not been directly stud ied.
DQ2/8 associated disease risk is known to be modi fied across individuals or populations varying in eth nic background, geography or gender [1923] . Moreover, DQ2/8 prevalence in Southern Italians has not been characterized. Thus, in this study we sought to first de fine the prevalence of HLA DQ2/8 alleles in a Southern Italy nonceliac GI tertiary ambulatory clinic popula tion. Subsequently, we desired to determine what HLA DQ2/8 haplotypes, if any, were associated with specific liver/GI diseases.
MATERIALS AND METHODS

Subject population
Patients (n = 463) from the gastroenterology ambulatory clinics of three hospitals were recruited over a period of three months. Three hundred and twentytwo subjects were recruited from University of Federico Ⅱ, Naples, Italy, 85 from Loreto Crispi Hospital, Naples, Italy and 56 from Ruggi D'Aragona Hospital, Salerno, Italy. During consultation patient's demographics and disease history were recorded. Disease status was classified according to the nature of presenting problem. Separate categories were attributed generally to pre or postliver transplant treatment for chronic viral hepatitis, upper functional and organic GI (gastritis, esophagitis) diseases, lower func tional (IBS) and lower inflammatory GI (IBD) diseases. Those with IBS were diagnosed via Rome Ⅲ criteria. Overall population characteristics are described in Table 1 . Participants were excluded from this study if they had missing data on disease status, multiple upper GI diseases or a prior diagnosis of celiac disease (n = 20).
Informed consent was obtained from each patient or patient guardian prior to study enrollment. The study was approved by ethics review board of the University of Naples "Federico Ⅱ" and complied with the Helsinki Ⅱ declaration.
Sample collection and analysis
Peripheral blood was collected in ethylenediaminote traacetic tubes and stored at 4 ℃. Genomic DNA was isolated and polymerase chain reaction with sequence specific primer was then performed to test solely for the presence/absence of DQ2/8 genes (Celiac Gene Screen, BioDiagene, Palermo, Italy). If patients were "susceptible to celiac disease", further analysis was performed to dis cern specific alleles known to be associated with celiac disease risk (Celiac Gene Alleles, BioDiagene, Palermo, Italy). Fluorescence detection of DQ2/8 was performed using BioRun Reader (Celiac Gene Alleles, BioDiagene, Palermo, Italy). Patients "susceptible to celiac disease" are generally understood to have at least one of the HLA DQ2/8 alpha or beta alleles.
Using fluoro-immuno-assay, with human recombinant tTg as an antigen, patients positive for HLA DQ2/DQ8 alleles were tested for antitTg antibodies (atTg) and ade quate immunoglobulin A (IgA) levels (CeliKey IgA, EliA, Phadia Freiburg, Germany). Antitissue transglutaminase levels greater than 10 (EliA U/mL) were considered posi tive. Those values between 7 and 10 (EliA U/mL) were considered equivocal and those less than 7 (EliA U/mL) negative. In later analysis both positive and equivocal groups were combined to increase power. None of the patients tested for total IgA were found to be deficient. Due to laboratory error several (n = 46) patients' atTg levels were unattainable.
Healthy controls
In order to compare the distribution of DQ2/8 alleles in study participants to the general Italian population we incorporated data from a prior published study by Megiorni et al [21] . Healthy participants consisted of 292 healthy and 259 family based controls from Rome, Italy. The prevalence of DQ2.5/8 in healthy controls was 29%. This increased to 39% after incorporating the less com mon DQ2 isoforms. DQ2/8 haplotypes were classified by Megiorni et al [8] . DQ2 positivity was defined as DQA1*05 in cohort with DQB2*02 (DQ2.5), or DQA1*0201 (DQ2.2)/DQA1*03 (DQ2.3) with B1*02. DQ8 positivity was defined as DQA1*03 with DQB1*0302.
HLA classification
Statistical analysis
The Pearson χ 2 test was performed on categorical data regarding demographics and the overall relationship of prevalence data. Fisher's exact test was used for analysis of data with cell counts n < 5. Basic tabular analysis was also performed to obtain odds ratios. A cutoff of P = 0.05 was considered significant; all intervals were report ed at 95% confidence. The analysis was performed using SAS 9.2 and SPSS 19.
RESULTS
We performed a crosssectional analysis of HLA DQ2/8 allele prevalence in a Southern Italian population of patients afflicted with either liver or other digestive dis eases outside of celiac disease. DQ2/8 haplotypes were stratified using a prior defined risk gradient relevant to celiac disease and prevalence in our disease population was compared to estimates in healthy controls.
Prevalence of HLA alleles in study population
From the patients included in our analysis, 196/443 (44.2%; 95%CI: 39.6%48.9%) were considered to be HLA DQ2/8 positive, regardless of disease status. With in those who were positive 144/197 (73.1%) had DQ2.5 and/or DQ8. Table 2 details the prevalence of HLA DQ2/8 by age, gender and GI disease in the study's par ticipants. The overall difference in DQ2/8 prevalence be tween these disease groups was not statistically significant (P = 0.21).
Comparison of DQ2/8 prevalence in study population to healthy controls Subjects DQ2/8 alleles were organized highest to lowest genetic risk of celiac disease, as described in Megiorni et al [8] and compared to healthy controls. No statistically significant difference in HLA DQ2/8 prevalence be tween our subject population and healthy controls was found (P = 0.16). As with healthy controls, study sub jects clustered towards lower celiac disease risk DQ2/8 alleles with DQ2.5 heterozygotes lying in the majority. Odds ratio calculations revealed that those with func tional gastric/esophageal disorders had a 1.8 fold higher odds of being HLA DQ2/8 positive as compared to healthy controls. Patients with organic gastric/esopha geal disorders had 1.3 higher odds of DQ2/8 positivity as compared to healthy controls. The odds were also in creased in the liver disease group and decreased in IBS/ IBD groups although these values were not significant (Table 3) .
α-tTg
Out of the patients with atTg data available no atTg positive patients were found in the liver disease/trans plant and inflammatory bowel group. One out of sixty- four (1.54%) subjects with functional gastric/esophageal issues and 4/90 (4.26%) with lower functional syndrome were found to be positive (P = 0.04; Table 4 ).
DISCUSSION
The clinical importance of HLA genetic testing has been established in several diseases [3, 24] . In this study we per formed a crosssectional analysis on a Southern Italian population with the goal of investigating the prevalence of several HLA DQ2/8 serotypes in those with GI is sues outside of celiac disease.
HLA DQ2/8 prevalence in Italy is thought to be between 30% and 40%, although this estimate may vary by geographic subpopulation [8, 24] . Nearly half of the sub jects in this study (44%) were considered HLA DQ2/8 positive. A lesser proportion of those with IBS/IBD were HLA DQ2/8 positive although these differences were not significant (P = 0.21) ( Table 2 ). Within those who were HLA DQ2/8 positive the majority possessed low risk celiac disease alleles (Table 5) . Thus, our results suggest that DQ2/8 haplotypes may play a role in liver/ digestive disease through pathological mechanisms dif ferent from those of celiac disease.
Several studies have established significant associations between DQ2, primary sclerosing cholangitis and hepatitis C virus recurrence after transplant [25, 26] . The large propor tion (46%) of DQ2/8 positive viral hepatitis patients in our study population agrees with the hypothesis that these haplotypes may be involved in certain liver disease patho genesis.
Differentiating between functional and organic GI disease can be difficult yet is important due to the im pacts on clinical decisionmaking. In this study we strati fied our patient population based on upper and lower functional or organic GI disorders. Several studies have directly compared DQ2/8 haplotype prevalence in upper organic GI disease. Lucendo et al [14] previously demon strated a null association between DQ2/8 and eosino philic esophagitis. Interestingly, DR3 and DR4 have been significantly linked with atrophic gastritis in a similar Ital ian population [27] . The positive yet non-significant rela tionship between our organic gastric/esophageal patients and DQ2/8 may be a consequence of the various upper GI organic diseases captured in our patient population. Unfortunately, due to sample size restrictions, we were not able to stratify by specific disease. Ultimately these findings suggest that it may be inappropriate to general ize upper organic GI disease as one confluent group be cause it is unknown whether the lack of a significant as sociation was truly due to causal or confounding disease factors.
Functional GI disorders represent the majority of GI cases yet many have etiologies, which are poorly under stood. Whether it is genetic abnormalities, psychological factors or other environmental variables, functional dis orders can represent complex, difficult to solve cases [28] . The strongest evidence of an association with DQ2/8 in this study was found in patients with functional upper GI disorders. Patients in this study had 1.8 higher odds of DQ2/8 positivity if they had an upper functional GI dis order as compared to healthy controls. This may signify that the risk of functional upper GI onset or recurrence is modified by the presence of particular DQ2/8 haplo types. Currently, the only published data, which could be used to comment on these findings, relates to celiac dis ease and DQ2/8. For example, Ford et al [29] conducted a metaanalysis, which found no association between celiac disease and functional dyspepsia. Overall, it is too early to decide whether DQ2/8 could be used to differentiate functional vs organic disease or at least be incorporated into a clinical algorithm that dictates likelihood of dis ease.
Known immunological associations between IBD and DR7, which is linked to both DQ2 and DQ8 hap lotypes have been established [17, 30] . Prior prevalence data though suggests that IBD, particularly Crohn's disease, is lower in individuals with the DQ2/8 linked celiac dis ease [12] . The relative modest prevalence of IBD (39%) in our study supports this notion. IBS has also been linked to HLA DQ2/8 haplotypes and bowel transit speeds [16, 31] . Additionally several studies have demonstrated that those with IBS and DQ2/8 positivity tend to present with symp toms indicative of gluten sensitivity and are responsive to a glutenfree diet [31, 32] . Out of all of the disease groupings those with IBS had the lowest prevalence of DQ2/8 posi tivity (36%). As those on a glutenfree diet were excluded from this study this may account for the low prevalence DQ2/8 positivity in those with IBS.
A small part of this study wished to obtain a base line level of atTg positive patients in a previously di agnosed GI population (Table 4) . If these patients were assumed to have celiac disease, these results correspond with known prevalence estimates of the disease [5] . Those who had prior diagnosed celiac disease or were adhering to a glutenfree diet were excluded from the study. It is thought to be common for patients with general abdominal pain, diarrhea and/or nausea to ex periment with a glutenfree diet in an attempt to ame liorate symptoms [33] . As such, removing individuals who may have experimented with this type of diet eliminated a potentially large source of bias. An additional strength of this study was the precision with which HLA haplo types and disease types were measured. Barring labora tory error, the HLA typing assays in this study have been shown to have near perfect sensitivity and specificity [34] . During blood collection patient's disease status was re corded. Thus, it was also unlikely that the classification of disease was subject to recall bias.
This study aimed to generally define HLA DQ2/8 pre valence in diseases/disorders that may be linked to celiac disease. As such there were several limitations, which could have potentially biased the results. The crosssec tional nature limited the collection of subject's lifestyle and disease history. Therefore, data such as age of dis ease onset and severity were unavailable. The Southern Italian population is typically generically and environmen tally homogenous thus unmeasured confounders would not significantly influence the results. Controls from the study were described as "healthy". We know from Me giorni et al [8] that these participants did not have celiac disease but it is possible they were afflicted with a liver or GI disease. This type of bias would have most likely pushed the magnitude of our estimates towards the null, masking potential associations. The small sample size in our study also limited our ability to make statistically sig nificant conclusions and investigate specific DQ2/8 allele associations.
Due to the limitations of the present study it may be difficult to make truly suggestive conclusions regarding the relationship between HLA DQ2/8 positive patients and liver/GI conditions. This study though has taken the first step through implying a potential association be tween specific HLA DQ2/8 alleles and GI disease patho genesis. Reproducibility of these results may eventually lead to the creation of clinical markers of elusive disease onset, such as in IBS or other clinically ambiguous disor ders [11, 16, 28, 35, 36] . Future studies should involve expanding the number of study participants in order to look at spe cific DQ2 alleles or investigating the shared influence of nonHLA celiac disease risk alleles.
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COMMENTS
Background
Human leukocyte antigen (HLA) DQ2/8 alleles and associated haplotypes are important players in the pathogenesis of several autoimmune diseases, particularly celiac disease. The distribution of DQ2/8 alleles in gastrointestinal (GI) disease outside of celiac disease though has been poorly established.
Research frontiers
HLA DQ2/8 alleles in patients can be easily tested with currently laboratory capabilities. Knowledge of HLA DQ2/8 frequencies related to autoimmune disease is being used to identify high risk populations and drive clinical recommendations regarding DQ2/8 gene testing.
Innovations and breakthroughs
Similar studies have described HLA DQ2/8 risk alleles in diseases such as type 1 diabetes or celiac disease. For example, in celiac disease those with one or more of the DQ2.5/8 alleles are at highest risk of disease onset. To date no studies have directly compared DQ2/8 prevalence in GI disease outside of celiac disease. By comparing the prevalence of HLA DQ2/8 to that of healthy controls we demonstrated that, like celiac disease, those with liver disease and esophageal/gastric disorders (both organic and functional) are more likely to be DQ2/8 positive.
Applications
Although this study is preliminary in nature, the results suggest that the development of novel clinical susceptibility markers of GI disease may exist. Particular DQ2/8 polymorphisms may point to increased risk of certain liver or esophageal/gastric disease.
Peer review
The study investigated the prevalence of HLA DQ2/8 alleles in Southern Italians with liver and GI diseases outside of celiac disease. The proportion of individuals HLA DQ2/8 positive resulted higher in those with liver/gastric or esophageal GI disease and lower in irritable bowel syndrome/inflammatory bowel disease as compared to general population estimates. The study is well designed and conduced. 
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